Stock listing

NASDAQ:BSEM BioStem Technologies, Inc. Stock

Follow BioStem Technologies, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BSEM

$0.635 USD -0.073 (-10.3%)

Close on Nov 20, 2026

Past year -83.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.535 – $0.710 USDNov 20, 2026
Volume
254,190 sharesNov 20, 2026
Market cap
$12.18M USDAt the close on Nov 20, 2026 · price × 19.18M shares outstanding
52-week range
$0.535 – $8.400 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$457,085 USDMedian day 144,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
BioStem Technologies, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BSEM · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.635-0.073-10.3%$0.700$0.710$0.535254,190
$0.708-0.110-13.4%$0.936$0.940$0.700323,500
$0.818-0.117-12.5%$0.951$0.952$0.810187,100
$0.935-0.025-2.6%$0.970$1.000$0.894241,500
$0.960-0.090-8.6%$1.200$1.240$0.960225,900
$1.050-0.250-19.2%$1.215$1.250$0.900450,300
$1.300-0.170-11.6%$1.435$1.599$1.280400,800
$1.470+0.430+41.3%$1.020$1.530$1.0201,132,300
$1.040-0.080-7.1%$1.080$1.290$1.000445,100
$1.120-0.010-0.9%$1.120$1.280$1.060179,900
$1.130+0.090+8.7%$1.030$1.150$1.010100,800
$1.040-0.110-9.6%$1.170$1.170$1.010197,100
$1.1500.0000.0%$1.180$1.200$1.120195,400
$1.150-0.010-0.9%$1.210$1.270$1.040297,000
$1.160+0.040+3.6%$1.200$1.290$1.140194,000
$1.120-0.170-13.2%$1.290$1.290$1.110145,400
$1.290-0.220-14.6%$1.540$1.590$1.210262,400
$1.510+0.030+2.0%$1.606$1.620$1.450327,700
$1.480-0.060-3.9%$1.590$1.600$1.420185,700
$1.540-0.030-1.9%$1.570$1.610$1.400169,500
$1.570-0.090-5.4%$1.680$1.740$1.570133,900
$1.660-0.020-1.2%$1.640$1.700$1.60049,600
$1.680+0.040+2.4%$1.620$1.780$1.550197,200
$1.640+0.100+6.5%$1.580$1.750$1.570163,400
$1.540-0.550-26.3%$2.100$2.100$1.450403,700
$2.090+0.050+2.5%$2.030$2.100$2.03033,300
$2.040-0.070-3.3%$2.150$2.300$1.880102,400
$2.110-0.140-6.2%$2.160$2.299$2.10070,000
$2.250-0.190-7.8%$2.490$2.490$2.132112,300
$2.440-0.030-1.2%$2.460$2.495$2.37036,800
$2.470-0.170-6.4%$2.600$2.700$2.46066,100
$2.640+0.250+10.5%$2.400$2.770$2.360252,900
$2.390-0.080-3.2%$2.500$2.690$2.36087,300
$2.470-0.285-10.3%$2.760$2.790$2.450128,600
$2.755+0.025+0.9%$2.740$2.827$2.582120,800
$2.730-0.340-11.1%$3.030$3.070$2.690157,700
$3.070-0.020-0.6%$3.100$3.241$3.04090,800
$3.090-0.740-19.3%$3.800$3.837$3.000332,100
$3.830-0.220-5.4%$4.000$4.100$3.81049,800
$4.050-0.090-2.2%$4.080$4.322$3.850181,700
$4.140+0.260+6.7%$3.850$4.280$3.810276,900
$3.880+0.080+2.1%$3.780$4.049$3.780150,500
$3.800-0.180-4.5%$3.920$4.050$3.76084,000
$3.980-0.420-9.5%$4.360$4.614$3.950129,600
$4.400-0.340-7.2%$5.200$5.247$4.400237,500
$4.740+0.380+8.7%$4.250$5.440$4.240857,100
$4.360+0.280+6.9%$4.180$4.500$4.060119,600
$4.080+0.070+1.7%$3.960$4.340$3.96076,400
$4.010-0.200-4.8%$4.150$4.350$3.900114,700
$4.210-0.100-2.3%$4.410$4.500$4.160140,100
$4.310+0.135+3.2%$4.230$4.450$4.170143,000
$4.175-0.035-0.8%$4.130$4.300$4.13093,800
$4.210+0.210+5.2%$4.050$4.300$4.040117,700
$4.000+0.290+7.8%$3.880$4.650$3.865389,700
$3.710+0.100+2.8%$3.630$3.850$3.59087,500
$3.610+0.070+2.0%$3.560$3.880$3.560100,300
$3.540+0.040+1.1%$3.500$3.620$3.42060,700
$3.500-0.180-4.9%$3.680$3.760$3.50089,800
$3.680+0.150+4.2%$3.500$4.050$3.500196,400
$3.530-0.320-8.3%$3.800$3.825$3.53053,900
$3.850+0.190+5.2%$3.660$3.910$3.66064,500
$3.660-0.150-3.9%$3.820$3.910$3.66030,400
$3.810-0.110-2.8%$3.870$3.990$3.75062,700
$3.920+0.380+10.7%$3.770$3.950$3.550112,700
$3.540-0.140-3.8%$3.690$3.800$3.50063,400
$3.680+0.335+10.0%$3.510$3.860$3.510155,000

Splits

3 splits since 2008 · NASDAQ:BSEM · every price before a split is adjusted for it

DayRatioWhat
1-for-400Consolidation
1-for-35Consolidation
1-for-1000Consolidation
Ticker
NASDAQ:BSEM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All BioStem Technologies, Inc. news

BioStem Technologies, Inc. on 6ix

News releases
2 in the last 12 months · 2 in all · newest Nov 12, 2026 · oldest 2026
Decks
9 decks · latest September 2026

Valuation

balance Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$11.21M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.7×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.60

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
7.00 USD · Analysts' mean
EPS, year to Dec 2026
-1.90 · 1 analyst
Revenue, year to Dec 2026
28.74M · 1 analyst

Team and board

OfficerRole
Jason MatuszewskiChief Executive Officer
Brandon PoeChief Financial Officer
Andrew Van VurstChief Operating Officer
Katherine GorrellChief Legal and Compliance Officer
Jeff HumkeVice President of Human Resources
Lita LillyVice President of Sales
Noah AgronVice President of Corporate Finance and Strategy
Vicky OxleyVice President of Marketing
Wendy W. WestonVice President of Research and Development
Barry HassettChief Commercial Officer
Michael FortunatoChief Accounting Officer

Events

QuarterResultsShare move
Q2 2026Aug 13, 2026 · After close+3.5%
Quarter to Mar 31, 2026May 14, 2026 · After close−14.2%
Q3 2025Nov 13, 2025 · After close−4.0%
Q2 2025Aug 13, 2025 · After close−2.8%
Quarter to Mar 31, 2025May 11, 2025 · After close+0.6%
Quarter to Dec 31, 2024Mar 31, 2025 · Before open−5.8%
Quarter to Sep 30, 2024Nov 11, 2024 · After close+1.1%
Quarter to Jun 30, 2024Aug 12, 2024 · After close+8.4%
Quarter to Mar 31, 2024May 14, 2024 · After close+4.6%
Quarter to Dec 31, 2023Feb 28, 2024−1.4%
All 19 quarters
QuarterResultsShare move
Quarter to Sep 30, 2023Nov 13, 2023 · After close+4.8%
Quarter to Jun 30, 2023Aug 2, 2023 · After close+8.3%
Quarter to Mar 31, 2023May 22, 2023
Quarter to Sep 30, 2022Nov 15, 2022 · After close−33.3%
Quarter to Jun 30, 2022Aug 22, 2022 · After close−3.3%
Quarter to Mar 31, 2022May 16, 2022 · After close+60.8%
Quarter to Dec 31, 2021Mar 31, 2022 · After close−5.6%
Quarter to Jun 30, 2021Aug 24, 2021+1.9%
Quarter to Mar 31, 2021Apr 6, 2021−1.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck21 slidesSeptember 2026
Q2 2026 Earnings PresentationEarnings22 slidesAugust 2026
Planet Microcap Conference Las Vegas 2026Conference17 slidesJun 17, 2026
Investor Presentation (April 2026)Investor deck20 slidesApril 2026
Investor Presentation (March 2026)Investor deck21 slidesMarch 2026
Q4 2025 Earnings PresentationEarnings20 slidesMarch 2026
JP Morgan Healthcare Conference 2026Conference24 slidesJanuary 2026
Investor Presentation (March 2025)Investor deck31 slidesMarch 2025
Investor Presentation (October 2024)Investor deck25 slidesOctober 2024

Open Decks

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 19, 2026Insider tradeSEC
424B3 · ProspectusNov 19, 2026Offer documentSEC
424B3 · ProspectusNov 19, 2026Offer documentSEC
424B3 · ProspectusNov 19, 2026Offer documentSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
All 87 filings
FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 5, 2026Big-stake noticeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
SEC STAFF LETTEROct 16, 2026Other filingsSEC
424B3 · ProspectusOct 13, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 13, 2026Other filingsSEC
4 · Change in ownershipOct 9, 2026Insider tradeSEC
4 · Change in ownershipOct 9, 2026Insider tradeSEC
DOct 9, 2026Other filingsSEC
CORRESP · Letter to the SECOct 8, 2026Other filingsSEC
UPLOAD · Letter from the SECOct 8, 2026Other filingsSEC
S-8 · Registration statement for employee plansOct 6, 2026Offer documentSEC
S-1 · Registration statementOct 2, 2026Offer documentSEC
8-K · Current reportSep 30, 2026Material contractSEC
EFFECT · Notice that a registration is effectiveSep 30, 2026Other filingsSEC
424B3 · ProspectusSep 29, 2026Offer documentSEC
CORRESP · Letter to the SECSep 25, 2026Other filingsSEC
UPLOAD · Letter from the SECSep 25, 2026Other filingsSEC
DSep 21, 2026Other filingsSEC
S-1 · Registration statementSep 18, 2026Offer documentSEC
8-K · Current reportSep 18, 2026Material contractSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 14, 2026Insider tradeSEC
424B3 · ProspectusAug 14, 2026Offer documentSEC
424B3 · ProspectusAug 13, 2026Offer documentSEC
8-K · Current reportAug 12, 2026ResultsSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
EFFECT · Notice that a registration is effectiveAug 12, 2026Other filingsSEC
S-1/A · Registration statement, amendedAug 7, 2026Offer documentSEC
8-K · Current reportAug 7, 2026Current reportSEC
SEC STAFF ACTIONAug 7, 2026Other filingsSEC
CERT · Exchange's certificate of listingAug 6, 2026Other filingsSEC
CORRESP · Letter to the SECAug 4, 2026Other filingsSEC
CORRESP · Letter to the SECAug 4, 2026Other filingsSEC
10-12B/AAug 4, 2026Other filingsSEC
S-1 · Registration statementJul 29, 2026Offer documentSEC
CORRESP · Letter to the SECJul 24, 2026Other filingsSEC
10-12B/AJul 24, 2026Other filingsSEC
UPLOAD · Letter from the SECJul 22, 2026Other filingsSEC
CORRESP · Letter to the SECJul 9, 2026Other filingsSEC
10-12GJul 9, 2026Other filingsSEC
UPLOAD · Letter from the SECJun 15, 2026Other filingsSEC
DJun 3, 2026Other filingsSEC
DRSLTR · Letter to the SEC with a draftMay 28, 2026Other filingsSEC
DRS/A · Draft registration statement, amendedMay 28, 2026Offer documentSEC
SEC STAFF LETTERMay 27, 2026Other filingsSEC
UPLOAD · Letter from the SECMay 18, 2026Other filingsSEC
DRS · Draft registration statementApr 17, 2026Offer documentSEC
RW · Request to withdraw a registrationOct 28, 2025Other filingsSEC
10-12B/AJan 22, 2025Other filingsSEC
10-12B/ANov 27, 2024Other filingsSEC
10-12BSep 27, 2024Other filingsSEC
DApr 4, 2023Other filingsSEC
DMay 25, 2021Other filingsSEC
DAug 16, 2016Other filingsSEC
DFeb 1, 2016Other filingsSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from BioStem Technologies, Inc.’s releases · as of Nov 11, 2026

Common shares
19,178,631
Fully diluted
19,178,631

Fully diluted

LineSharesAs of
Common shares19,178,631Nov 11, 2026

Share count over time

CountShares
Nov 11, 202619,178,631
Sep 30, 202618,679,490

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard574K3.0%US$1.77MSep 30, 2026
PNC Financial Services Group, Inc.544K2.8%US$1.68MSep 30, 2026
Anson Funds Management LP368K1.9%US$1.22MSep 30, 2026
Geode Capital141K0.74%US$437KSep 30, 2026
Northern Trust33,4210.17%US$103KSep 30, 2026
Millennium23,9900.13%US$74,129Sep 30, 2026
UBS19,9690.10%US$61,704Sep 30, 2026
Virtu Financial LLC18,8300.10%US$58,000Sep 30, 2026
StoneX Group Inc.18,2510.10%US$60,625Sep 30, 2026
Elequin Capital, LP10,6140.06%US$32,797Sep 30, 2026
All 23 holders
HolderSharesOf the companyValueAs of
Ashton Thomas Private Wealth, LLC10,0780.05%US$31,141Sep 30, 2026
Beaird Harris Wealth Management, LLC2,0000.01%US$6,180Sep 30, 2026
Osaic Holdings, Inc.1,550<0.01%US$4,826Sep 30, 2026
Tower Research Capital LLC (TRC)760<0.01%US$2,348Sep 30, 2026
Atlantic Union Bankshares Corp500<0.01%US$1,545Sep 30, 2026
Gables Capital Management Inc.350<0.01%US$1,082Sep 30, 2026
Wolff Wiese Magana LLC350<0.01%US$1,082Sep 30, 2026
HighMark Wealth Management LLC250<0.01%US$772Sep 30, 2026
Global Retirement Partners, LLC200<0.01%US$618Sep 30, 2026
Fidelity100<0.01%US$309Sep 30, 2026
JPMorgan79<0.01%US$303Sep 30, 2026
Allworth Financial LP74<0.01%US$229Sep 30, 2026
Federation des caisses Desjardins du Quebec1<0.01%US$3Sep 30, 2026

Insider trades

TradeTradeSharesPriceValueDate
Matuszewski Jason
Director, Officer: Chief Executive Officer, 10% owner
Sale14,300USD 1.00US$14,300Nov 17, 2026

Big stakes

StakeStakeSharesDateFiling
Andrew Van Vurst18.40%3.85MSep 30, 2026Schedule 13G
Jason Matuszewski17.40%3.67MSep 30, 2026Schedule 13G
PNC Financial Services Group, Inc.10.40%1.94MOct 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark A. Glickman
Other companies: MetaVia Inc. (Independent Director · Since at least May 11, 2023); TherapeuticsMD, Inc. (Co-Chief Executive Officer · Oct 15, 2021 – Dec 6, 2022 · Past); Esperion Therapeutics, Inc. (Chief Commercial Officer · Dec 20, 2018 – Jan 2, 2020 · Past); Aralez Pharmaceuticals Inc (Chief Commercial Officer · Feb 5, 2016 – Mar 19, 2018 · Past); POZEN Inc (Chief Commercial Officer · Jun 22, 2015 – Jun 22, 2015 · Past); Auxilium Pharmaceuticals Inc (EVP - Sales and Marketing · Feb 3, 2012 – Jan 29, 2015 · Past)
Director · Since at least Aug 6, 2026
Andrew Van VurstChief Operating Officer · Since at least Nov 5, 2026
Barry HassettChief Commercial Officer · Since at least Aug 6, 2026
Brandon PoeChief Financial Officer · Since at least Aug 6, 2026
Hannaway Rayna LesserDirector · Since at least Aug 6, 2026
Jason MatuszewskiChief Executive Officer · Since at least Nov 5, 2026
Jeff HumkeVice President of Human Resources · Since at least Nov 4, 2026
Jodi UngrodtDirector · Since at least Aug 6, 2026
Katherine GorrellChief Legal and Compliance Officer · Since at least Aug 6, 2026
Kenneth Howard Warrington JrDirector · Since at least Aug 6, 2026
All 17 people
PersonSeat
Lita LillyVice President of Sales · Since at least Nov 5, 2026
Michael FortunatoChief Accounting Officer · Since at least Aug 6, 2026
Noah AgronVice President of Corporate Finance and Strategy · Since at least Nov 5, 2026
Steven D SonenreichDirector · Since at least Aug 6, 2026
Vicky OxleyVice President of Marketing · Since at least Nov 4, 2026
Vurst Andrew Smith-VanChief Operating Officer, Director · Since at least Aug 6, 2026
Wendy W. WestonVice President of Research and Development · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about BioStem Technologies, Inc.